Cogstate Limited (ASX:CGS)
2.750
-0.020 (-0.72%)
Nov 6, 2025, 4:11 PM AEST
Cogstate Market Cap
Cogstate has a market cap or net worth of 469.77 million as of November 6, 2025. Its market cap has increased by 183.44% in one year.
Market Cap
469.77M
Enterprise Value
416.24M
Revenue
80.98M
Ranking
n/a
PE Ratio
30.93
Stock Price
2.75
Market Cap Chart
Since February 16, 2004, Cogstate's market cap has increased from 4.34M to 469.77M, an increase of 10,717.64%. That is a compound annual growth rate of 24.05%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 6, 2025 | 469.77M | 162.40% |
| Dec 31, 2024 | 179.03M | -27.11% |
| Dec 29, 2023 | 245.63M | -27.75% |
| Dec 30, 2022 | 339.98M | -18.95% |
| Dec 31, 2021 | 419.47M | 124.00% |
| Dec 31, 2020 | 187.26M | 185.38% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CSL Limited | 86.75B |
| Pro Medicus | 26.54B |
| Cochlear | 18.64B |
| Sonic Healthcare | 10.23B |
| Ramsay Health Care | 7.11B |
| Ansell | 5.18B |
| Telix Pharmaceuticals | 5.13B |
| Mesoblast | 2.94B |